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Ywhen enhanced motion occurred in mid or apical segments than when they did not
(p¼0.01, 0.005, respectively). d-IVV correlated with d-WMSI of the mid and apical
levels (r¼0.48, 0.42, p¼0.01, 0.03), while it did not for the basal level (r¼0.21, p¼0.3).
ROC-curve showed that d-IVV detects global viability effectively (AUC¼0.761), how-
ever, sensitivity and speciﬁcity increased for mid and apical levels (AUC¼0.790,
0.868).
CONCLUSION Mitral annular longitudinal motion during isovolumic contraction,
represented by IVV and d-IVV, increase after LDDE in the presence of viable
myocardium. Changes that occur in the mid and apical segments of the LV seem to
contribute more to this effect than the basal segments.OTHER
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BACKGROUND Smartphone applications (apps) in healthcare are being increasingly
developed with the aim of beneﬁting both patients and their physicians. The delivery
of adequate instructions both before and after a procedure is important in ensuring
the best outcome for patients. Failure to comply with instructions after a procedure
can increase the risk of complications.
STUDY We conducted a prospective evaluation of a new smartphone app designed to
provide pre- and post-operative instructions (TrackMyRecovery). The app also
permitted patients to securely send images of their wound and pain scores. The
primary end points were patients’ compliance with reading instructions, sending
wound images and pain levels. The secondary endpoint was any post-procedural
related complications.
METHODS The instructions were tailored according to the physician’s preferences
and were associated with reminders in the form of push notiﬁcations that patients
would receive on their iPhones or iPads. Ten patients undergoing routine cardiac
procedures were selected. Once securely registered, the patients’ instructions were
available on the app. Through the app, patients were prompted to read pre and post-
operative instructions. Patients also received speciﬁc reminders before and after their
procedure via push-notiﬁcations. The patients’ progress both pre and post-procedure
was sent to a newsfeed on a secured web portal, where physicians had full access.
After completing use of the app, patients were asked to complete an online survey.
The web portal and app were developed using a standard HIPAA compliant privacy
policy.
RESULTS 10 patients undergoing pacemaker implantation or Left Heart Catheteri-
zation were prospectively accrued. All 10 patients successfully registered with the
app, read and complied with instructions. There were no cancelled procedures or
post-operative complications.
CONCLUSION A smartphone app developed for perioperative care was used effec-
tively in a small cohort of 10 patients undergoing routine cardiology procedures. It
ensured 100% compliance with instructions along with excellent patient satisfaction
scores . The use of electronic instructions on a smartphone or tablet with built-in
reminders and the ability to send secure data to physicians could improve periop-
erative care, ensure compliance, and reduce post-operative complications. A larger
cohort of patients with long-term follow-up across various medical disciplines is
necessary to corroborate these ﬁndings.CRT-709
Cardiac Output Confusion. Why Your Cardiac Catheterization Lab Computer
System May Not Give You The Results You Expect And Need?
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BACKGROUND Accurate assessment of Cardiac Output (CO) is a critical measurement
in the cardiac catheterization laboratory (CCL), especially in calculation of aortic
valve area (AVA). Due to known inaccuracy of Fick assumptions, many measure
Thermodilution (TD) CO as well. Most physicians assume that this more accurate
measurement can be chosen to determine AVA. However, we have discovered that
our popular computer system [Philips Xper Connect (XIM)] will use predetermined
rules to assign one of the CO methods for the reported AVA.
METHODS We randomly selected one hundred consecutive patients who underwent
right and left heart catheterization from 2009-2012 for assessment of aortic valve
areas and had both Fick CO calculated using femoral and pulmonary arterial satura-
tions and thermodilution CO performed for calculation of AVA. We then examined
our XIMS system records for each of these procedures and documented the timingwhen each CO method was performed and reviewed which CO and AVA calculation
appeared on the ﬁnal catheterization report.
RESULTS We found that whichever CO calculation was done ﬁrst by the CCL com-
puter system became the determinative output, appearing on the ﬁnal report and
being used to calculate the ofﬁcial AVA. In 32 patients the CO and AVA were calcu-
lated and displayed using the Fick calculation method, which had been performed
ﬁrst, and in 68.
patients TD was performed ﬁrst and the AVA and CO were calculated and displayed
using this CO. Although the second CO type could be selected on the computer during
the case, and the computer screen would temporarily display the related AVA, this
would never appear in the ﬁnal report and may never be seen by the physician. Thus
the CO used ofﬁcially depended solely of the timing of the oxygen saturation samples.
An intense effort of 11 non-intuitive computer clicks and multiple screen changes is
required to make the second output the determinative value. The recommendation
for surgery (AVA <1.0 cm2) was different between the CO methods in 12 cases (12% of
patients).
CONCLUSION Our widely used computer system has an arbitrary method of selecting
the determinative CO to calculate the ﬁnal AVA. For the more accurate TD CO to
’trump’ the Fick CO an elaborate series of computer commands needs to be per-
formed. None of the physicians or technicians was aware of this computer selection
process, which affects critical treatment decisions.PERCUTANEOUS VALVE INTERVENTION
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BACKGROUND Transcatheter implantations of aortic valves (TAVR) have revolu-
tionized management of severe aortic stenosis. Speciﬁc complications have been
noted with ﬁrst-generation valves. Details of such were sought from the US Food and
Drug Administration (FDA) maintained MAUDE database which houses medical de-
vice reports submitted to the FDA by mandatory reporters (manufacturers, importers
and device user facilities) and voluntary reporters such as health care professionals,
patients and consumers.
METHODS A detailed search was conducted in PubMed, Cochrane Library, EMBASE
and CINAHL to identify adverse events reported with implantations of the ﬁrst gen-
eration Medtronic CoreValve(s). Then the FDA MAUDE database was queried from
January 2014 to August 31, 2014 to identify prevalence of the same complications as
reported to the FDA. Individual patient reports were identiﬁed and relevant data on
such complications were abstracted. Finally mortality outcomes from such patients
were abstracted, and associations of same for each individual reported complication
were identiﬁed in a multivariate logistic regression model.
RESULTS FDA MAUDE revealed 384 unique reports of complications with the ﬁrst
generation CoreValves. A total of 22 patients died peri-procedurally. The complica-
tions most strongly associated with peri-procedural mortality were development of
peri-procedural cardiogenic shock, ventricular tachycardia, development of post-
procedural atrial ﬁbrillation, acute renal failure and the need for valve-in-valve
procedure.(Table 1)
CONCLUSIONS Speciﬁc complications with the ﬁrst-generation Medtronic CoreValves
were strongly associated with mortality, and focused strategies to mitigate the same
may improve outcomes with future generations of this exciting new technology.
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Hemodynamic
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8420.929Atrial Fibrillation 37.7251 60.56209 2.26 0.024 1.622377 -
877.2209Central AI 0.073683 0.200761 -0.96 0.338 0.000353 -
15.36769Paravalvular AI 1.669573 1.778376 0.48 0.63 0.206982 -
13.46724CVA/Stroke 0.899917 1.59084 -0.06 0.952 0.02815 -
28.76906T
EValve Malposition 0.576193 0.706685 -0.45 0.653C
H0.052071 -
6.37593N
ONeed for Valve in Valve 0.023174 0.029696 -2.94 0.003L0.00188 -
0.285616O
GValve Migration 6.755297 8.962306 1.44 0.15Y0.50159 -
90.97882Need for BAV 0.389508 0.818652 -0.45 0.654 0.006331 -
23.96282Renal Failure 416.0855 1011.941 2.48 0.013 3.540119 -
48904.33RENAL DENERVATION
CRT-711
Accessory Renal Arteries And Blood Pressure-lowering Effects Of Renal
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BACKGROUND The bipolar radiofrequency Vessix Renal Denervation System (Boston
Scientiﬁc, Marlborough, MA) can be used in small arteries, allowing resistant hyper-
tension patients with accessory renal arteries to be included in the REDUCE-HTN
study.
METHODS Accessory renal arteries were identiﬁed and treated in 24 patients during
study procedures. Another 19 patients had accessory arteries that were later identi-
ﬁed in core lab angiographic analysis (ie, untreated accessory arteries). In post hoc
analyses, BP changes were compared between patients with treated vs untreated
accessory arteries, and between patients with accessory arteries (according to the
core lab) vs without.
RESULTS At both 6 and 12 months, all 4 patient subgroups had signiﬁcant ofﬁce
systolic BP reductions (p0.0004). For patients with treated accessory arteries, mean
ofﬁce BP decreased from 178.016.1/99.111.2 mmHg at baseline to 157.026.3/
86.814.5 mmHg at 6 months, and for patients with core lab-identiﬁed but untreatedaccessory arteries, ofﬁce BP decreased from 188.817.5/103.813.2 mmHg to
155.228.0/88.011.8 mmHg. None of the 6- or 12-month pairwise comparisons of
systolic BP for patients with treated vs untreated accessory arteries, or for those with
accessory arteries vs without, reached statistical signiﬁcance (Table). In linear
regression models, neither presence nor treatment of accessory arteries was signiﬁ-
cantly associated with the change in ofﬁce systolic BP.
CONCLUSION Presence of accessory renal arteries does not prevent signiﬁcant BP
reductions following renal denervation treatment. Due to the small sample sizes,
these unpowered post hoc analyses do not conclusively address the degree to which
accessory renal artery denervation may affect BP-lowering efﬁcacy.Table. Ofﬁce and 24-hours Ambulatory Systolic Blood Pressures and Accessory RenalCRT-712
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BACKGROUND Clinical and preclinical studies suggest that the efﬁcacy of RF renal
denervation (RDN) increases with increasing number of treatments. We evaluated
efﬁcacy and safety of the 9-electrode, 5-Fr, over-the-wire, RF ‘basket’ catheter, along
with simultaneous bipolar/unipolar therapy algorithm ReDy system (Renal Dynamics,
NJ) in pigs. Two catheter conﬁgurations were contrasted, with and without a ‘basket’-
covering membrane designed to minimize blood ﬂow at the electrode/tissue interface
thus minimizing shunting of RF power through blood.
METHODS Seven juvenile Yorkshire swine underwent bilateral temperature-
controlled RDN using the ReDy system. A single catheter size was used on all arteries
as the ReDy device accommodates artery diameters up to 6.5mm. Pigs were sacriﬁced
7-30d post treatment. Arteries were harvested for histopathology and kidneys pro-
cessed for norepinephrine (NEPI) quantiﬁcation.
RESULTS There was no angiographic evidence of acute dissection, perforation, or
occlusion at the time of the procedure. Macroscopic inspections of catheters post-
removal showed no adherent thrombus. Angiographic assessments showed the lu-
mens of all arteries were patent. Histologically, zones of treatment within arterial
walls and surrounding adventitia were well-demarcated at 7d with resolution of tis-
sue response over time. There was no evidence of any adverse effects on arteries or
surrounding tissue, and all treated arterial sections exhibited advanced re-
endothelialization.
The use of blood isolation membranes allowed for lower treatment powers (1.20.8
vs 1.40.2 W) and temperatures (63.66.3 vs 682.3 C) while increasing ablation
depth (5.02.6 vs 2.80.8 mm, p¼0.025) and percentage of affected nerves (37 vs
21%, P¼NS) at 7d, as estimated by histology and conﬁrmed by a signiﬁcant 60%
reduction in NEPI (256250 vs 634250 ng/g, p¼0.007). Tissue response was noted
in all quadrants and w65% of the artery length. Though radial adventitial response
was more compact at 30d, due to tissue repair, the percentage of affected nerves
(35%) and NEPI levels (365132 ng/g) were statistically equivalent to 7d values
(p>0.46).
CONCLUSION The Renal Dynamics ReDy system is safe and efﬁcacious in a porcine
RDN model. Utilization of non-occluding blood isolation membranes allowed for deep
delivery of RF power into the tissue at relatively low treatment powers, at multiple
axial and circumferential locations.
